Old Web
English
Sign In
Acemap
>
authorDetail
>
Christina Lourdes Mayer
Christina Lourdes Mayer
Janssen Pharmaceutica
Pharmacokinetics
Medicine
Pathology
Pharmacodynamics
ADME
4
Papers
1824
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Interim results of a phase 1/2 study of JNJ-63723283, an anti-PD-1 monoclonal antibody, in patients with advanced cancers.
2018
Journal of Clinical Oncology
Emiliano Calvo
Victor Moreno
Enriqueta Felip
Giuseppe Curigliano
Daniel Morgensztern
James Greger
Kyounghwa Bae
Christina Lourdes Mayer
Jennifer Marino
Edward F. Attiyeh
Hong Xie
James J. Lee
Show All
Source
Cite
Save
Citations (1)
Dose selection of siltuximab for multicentric Castleman's disease.
2015
Cancer Chemotherapy and Pharmacology
Christina Lourdes Mayer
Lanyi Xie
Rajesh Bandekar
Ming Qi
Helgi van de Velde
Manjula Reddy
Xiang Qin
Hugh M. Davis
Thomas A. Puchalski
Show All
Source
Cite
Save
Citations (9)
Prediction of Human Pharmacokineticsfor Protein-Based Biologic Therapeutics
2015
Chao Han
Christina Lourdes Mayer
Show All
Source
Cite
Save
Citations (1)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009
Journal of Clinical Oncology
Anja Rinke
Carmen Schade-Brittinger
K. J. Klose
Peter J. Barth
M. Wied
Christina Lourdes Mayer
Behnaz Aminossadati
Ulrich-Frank Pape
Jan Harder
Christian N. Arnold
Thomas M. Gress
R. Arnold
Show All
Source
Cite
Save
Citations (1813)
1